MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinomaopen access
- Authors
- Kim, So Yeon; An, Ji hyun; Lim, Young-Suk; Han, Seungbong; Lee, Ji-Young; Byun, Jae Ho; Won, Hyung Jin; Lee, So Jung; Lee, Han Chu; Lee, Yung Sang
- Issue Date
- Apr-2017
- Publisher
- AMER MEDICAL ASSOC
- Citation
- JAMA ONCOLOGY, v.3, no.4, pp.456 - 463
- Indexed
- SCIE
SCOPUS
- Journal Title
- JAMA ONCOLOGY
- Volume
- 3
- Number
- 4
- Start Page
- 456
- End Page
- 463
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/3546
- DOI
- 10.1001/jamaoncol.2016.3147
- ISSN
- 2374-2437
- Abstract
- IMPORTANCE
Current recommendations for patients with cirrhosis are to undergo surveillance for hepatocellular carcinoma (HCC) with ultrasonography (US) every 6 months. However, the sensitivity of US screening to detect early-stage HCC is suboptimal. Magnetic resonance imaging (MRI) with liver-specific contrast may detect additional HCCs missed by US in high-risk patients with cirrhosis.
OBJECTIVE
To compare the HCC detection rate of US and MRI in patients with cirrhosis who are at high risk for HCC.
DESIGN, SETTING, AND PARTICIPANTS
A prospective surveillance study of 407 patients with cirrhosis and an estimated annual risk of HCC greater than 5% who underwent 1 to 3 biannual screening examinations with paired US and liver-specific contrast-enhanced MRI at a tertiary care hospital between November 2011 and August 2014. All patients were followed-up with dynamic computed tomography (CT) at 6 months after the study. The confirmation of HCC was based on the results of histologic examination and/or typical CT images of HCC.
MAIN OUTCOMES AND MEASURES
HCC detection rates and false-positive findings of US vs MRI.
RESULTS
A total of 407 eligible patients received 1100 screenings with paired US and MRI. Hepatocellular carcinomas were diagnosed in 43 patients: 1 detected by US only, 26 by MRI only, 11 by both, and 5 were missed by both. The HCC detection rate of MRI was 86.0% (37/43), significantly higher than the 27.9%(12/43) of US (P <.001). Magnetic resonance imaging showed a significantly lower rate of false-positive findings than US (3.0% vs 5.6%; P =.004). Of the 43 patients with HCC, 32 (74.4%) had very early-stage HCC (a single nodule <2 cm), and 29 (67.4%) received curative treatments. The 3-year survival rate of the patients with HCC (86.0%) was not inferior to those without HCC (94.2%; hazard ratio, 2.26; 95% CI, 0.92-5.56; P =.08).
CONCLUSIONS AND RELEVANCE
In patients with cirrhosis at high-risk of HCC, screening that used MRI with liver-specific contrast resulted in a higher HCC detection rate and lower false-positive findings compared with US. With MRI screening, most of the cancers detected were at very early stage, which was associated with a high chance of curative treatments and favorable survival of patients. Whether surveillance with MRI would reduce mortality from HCC in high-risk patients requires further investigation.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/3546)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.